These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 23236229)

  • 1. Way back for fructose and liver metabolism: bench side to molecular insights.
    Rebollo A; Roglans N; Alegret M; Laguna JC
    World J Gastroenterol; 2012 Dec; 18(45):6552-9. PubMed ID: 23236229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Energy and fructose from beverages sweetened with sugar or high-fructose corn syrup pose a health risk for some people.
    Bray GA
    Adv Nutr; 2013 Mar; 4(2):220-5. PubMed ID: 23493538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soft drinks consumption and nonalcoholic fatty liver disease.
    Nseir W; Nassar F; Assy N
    World J Gastroenterol; 2010 Jun; 16(21):2579-88. PubMed ID: 20518077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sugar consumption, metabolic disease and obesity: The state of the controversy.
    Stanhope KL
    Crit Rev Clin Lab Sci; 2016; 53(1):52-67. PubMed ID: 26376619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential Effects of Chronic Ingestion of Refined Sugars versus Natural Sweeteners on Insulin Resistance and Hepatic Steatosis in a Rat Model of Diet-Induced Obesity.
    Valle M; St-Pierre P; Pilon G; Marette A
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32751772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fructose- and sucrose- but not glucose-sweetened beverages promote hepatic de novo lipogenesis: A randomized controlled trial.
    Geidl-Flueck B; Hochuli M; Németh Á; Eberl A; Derron N; Köfeler HC; Tappy L; Berneis K; Spinas GA; Gerber PA
    J Hepatol; 2021 Jul; 75(1):46-54. PubMed ID: 33684506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.
    Jensen T; Abdelmalek MF; Sullivan S; Nadeau KJ; Green M; Roncal C; Nakagawa T; Kuwabara M; Sato Y; Kang DH; Tolan DR; Sanchez-Lozada LG; Rosen HR; Lanaspa MA; Diehl AM; Johnson RJ
    J Hepatol; 2018 May; 68(5):1063-1075. PubMed ID: 29408694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fructose and metabolic diseases: new findings, new questions.
    Tappy L; Lê KA; Tran C; Paquot N
    Nutrition; 2010; 26(11-12):1044-9. PubMed ID: 20471804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of high-fructose corn syrup in metabolic syndrome and hypertension.
    Ferder L; Ferder MD; Inserra F
    Curr Hypertens Rep; 2010 Apr; 12(2):105-12. PubMed ID: 20424937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid fructose in pregnancy exacerbates fructose-induced dyslipidemia in adult female offspring.
    Rodríguez L; Panadero MI; Rodrigo S; Roglans N; Otero P; Álvarez-Millán JJ; Laguna JC; Bocos C
    J Nutr Biochem; 2016 Jun; 32():115-22. PubMed ID: 27142744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of liver fructokinase expression and improved hepatic inflammation and metabolism in liquid fructose-fed rats after atorvastatin treatment.
    Vilà L; Rebollo A; Ađalsteisson GS; Alegret M; Merlos M; Roglans N; Laguna JC
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):32-40. PubMed ID: 21122807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. French Recommendations for Sugar Intake in Adults: A Novel Approach Chosen by ANSES.
    Tappy L; Morio B; Azzout-Marniche D; Champ M; Gerber M; Houdart S; Mas E; Rizkalla S; Slama G; Mariotti F; Margaritis I
    Nutrients; 2018 Jul; 10(8):. PubMed ID: 30060614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-fructose corn syrup-55 consumption alters hepatic lipid metabolism and promotes triglyceride accumulation.
    Mock K; Lateef S; Benedito VA; Tou JC
    J Nutr Biochem; 2017 Jan; 39():32-39. PubMed ID: 27768909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dietary fructose in nonalcoholic fatty liver disease.
    Vos MB; Lavine JE
    Hepatology; 2013 Jun; 57(6):2525-31. PubMed ID: 23390127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic effects of fructose and the worldwide increase in obesity.
    Tappy L; Lê KA
    Physiol Rev; 2010 Jan; 90(1):23-46. PubMed ID: 20086073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Important Food Sources of Fructose-Containing Sugars and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Controlled Trials.
    Lee D; Chiavaroli L; Ayoub-Charette S; Khan TA; Zurbau A; Au-Yeung F; Cheung A; Liu Q; Qi X; Ahmed A; Choo VL; Blanco Mejia S; Malik VS; El-Sohemy A; de Souza RJ; Wolever TMS; Leiter LA; Kendall CWC; Jenkins DJA; Sievenpiper JL
    Nutrients; 2022 Jul; 14(14):. PubMed ID: 35889803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fructose and NAFLD: metabolic implications and models of induction in rats.
    Castro GS; Cardoso JF; Vannucchi H; Zucoloto S; Jordão AA
    Acta Cir Bras; 2011; 26 Suppl 2():45-50. PubMed ID: 22030814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and behavioural effects of sucrose and fructose/glucose drinks in the rat.
    Sheludiakova A; Rooney K; Boakes RA
    Eur J Nutr; 2012 Jun; 51(4):445-54. PubMed ID: 21800086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fructose consumption as a risk factor for non-alcoholic fatty liver disease.
    Ouyang X; Cirillo P; Sautin Y; McCall S; Bruchette JL; Diehl AM; Johnson RJ; Abdelmalek MF
    J Hepatol; 2008 Jun; 48(6):993-9. PubMed ID: 18395287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose and hepatic insulin resistance.
    Softic S; Stanhope KL; Boucher J; Divanovic S; Lanaspa MA; Johnson RJ; Kahn CR
    Crit Rev Clin Lab Sci; 2020 Aug; 57(5):308-322. PubMed ID: 31935149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.